STOCKHOLDERS' EQUITY - Common Stock (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2018 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2019 |
May 18, 2018 |
May 17, 2018 |
|
Controlled Equity Offering | ||||||
Authorized number of shares of common stock | 400,000,000 | 400,000,000 | ||||
Aggregate proceeds | $ 67,162 | $ 114,180 | ||||
Common stock | ||||||
Controlled Equity Offering | ||||||
Authorized number of shares of common stock | 400,000,000 | 200,000,000 | ||||
Number of shares of common stock sold (in shares) | 18,400,000 | 18,400,000 | 45,981,093 | |||
Share price (in dollars per share) | $ 3.90 |
X | ||||||||||
- Definition Represents information about the Controlled Equity Offering. No definition available.
|
X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|